Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001802768-25-000010
Filing Date
2025-02-12
Accepted
2025-02-12 09:20:05
Documents
89
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rprx-20241231.htm   iXBRL 10-K 2541256
2 EX-4.2 rprx-20241231ex42.htm EX-4.2 40277
3 EX-19.1 rprx-20241231ex191.htm EX-19.1 107163
4 EX-21.1 rprx-20241231ex211.htm EX-21.1 6533
5 EX-23.1 rprx-20241231ex231.htm EX-23.1 4185
6 EX-31.1 rprx-20241231ex311.htm EX-31.1 9335
7 EX-31.2 rprx-20241231ex312.htm EX-31.2 9400
8 EX-32 rprx-20241231ex32.htm EX-32 4943
14 rprx-20241231_g1.jpg GRAPHIC 71281
15 rprx-20241231_g2.jpg GRAPHIC 31979
16 rprx-20241231_g3.jpg GRAPHIC 99893
17 rprx-20241231_g4.jpg GRAPHIC 89214
  Complete submission text file 0001802768-25-000010.txt   12066672

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rprx-20241231.xsd EX-101.SCH 77209
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rprx-20241231_cal.xml EX-101.CAL 87921
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rprx-20241231_def.xml EX-101.DEF 432861
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rprx-20241231_lab.xml EX-101.LAB 823435
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rprx-20241231_pre.xml EX-101.PRE 603551
91 EXTRACTED XBRL INSTANCE DOCUMENT rprx-20241231_htm.xml XML 1673340
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39329 | Film No.: 25612417
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)